2000: Bewegen is Leven

Presentatie Drs. L. Pruimboom

8. Literatuur

Vuitton DA, de Wazières B, Dupond JL; Psychoimmunology; a questionable model; Rev Med Intern 1999 Oct 20:10, 934 – 46
Gleeson, Maree; Mucosal Immune Responses ans Risk of Respiratory Illness in Elite Athletes; Excercise Immunology Review 2000, 6: 5 – 42
Graham, NMH, Bartholomeusz CA, Taboonpong N, la Brooy JT; Does anxiety reduce the secretion rate ofsecretory IgA in saliva; Med J Aust 1988, 148: 131 – 133
Heim C, Ehlert U, Hellhamer DH; The potential role of hypocortisolism of stress-related bodily disorders; Psychoneuroendocrinology 2000, Jan 25:1, 1 – 35
Brandtzaeg P; Homing of mucosal immune cells – a possible connection between intestinal and articular inflammation; Alimentary Pharmacology and Therapeutics 1997, 11: 24 – 37
Brandtzaeg P; Humoral immune response patterns oh human mucosae: Induction and relation to bacterial respiratory tract infections; J Infect Dis 1992, 165: 167 – 176
Brandtzaeg P, Baekkevold ES, Farstad FL, Jahnse F, Johansen E, Nilson EM, Yamanaka T; Regional specilization in the mucosal immune system: what happens in the microcompartments; Immunol Today 1999, 20(3): 141 – 151
Pruimboom L; Fibromialgie; een psycho-neuro-immuno-endocrinologische aandoeningen; Arts en Apotheker 2000, 3: 2 – 14
Kaetzel CS, Robinson JK, Chintalacharuvu KR, Vaerman JP, Lamm ME; The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial tissue: A local defense function for IgA; Proc Natl Acad Sci USA; 1991, 88: 8796 – 880
Lamm ME; Cellular aspects of immunoglobulin A; Adv Immunol 1976, 22: 223 – 290
Mazanec MB, Kaetzel CS, Nedrun JG, Lamm ME; New thoughts on the rolr of immunoglobulin A in mucosal immunity; Mucosal Immunology Update 1993, 1: 13 – 15
Masi AT, Bijlsma JWJ, Chikanza IC, Pitzalis C, Cutolo M; Neuroendocrine, Immunologic, ans Microvascular Systems Interactions in Rheumatoid Arthritis; Physiopathogenetic and Therapeutic Perspectives; Sem in Arthr and Rheum 1999, oct 29:2, 65 – 81
Schedlowsky M; Psychoneuroimmunology; Spektrum 1996, 46 – 53
Masi, AT; Incidence of rheumatoid arthritis: cdo the observed age-sex interaction patterns support a role of androgenic-anabolic steroid deficiency in its pathogenesis?; Br J Rheumatol 1994, 33: 697 – 699
Schulkin, J; The Neuroendocrine Regulation of Behavior; cambridge University Press 1999, 145 – 179
Dam, B van; Script “Orthomoleculaire Geneeskunde”; Van Nature, 2000
Pruimboom, L; Script “Orthomoleculaire Geneeskunde”; Van Nature, 2000
Pruimboom, L, Dam B van; Chronische aandoeningen behandeld vanuit de psycho-neuro-immunologische benadering; Seminar Bonusan 1998
Aaseth J, Haugen M, Forre O; Rheumatoid arthritis ans metal compounds-perspectives on the role of oxigen radical detoxification; Analyst 1998, an 123:1, 3 – 6
Friedl Hp,Till GO, Ryan US, Ward PA; Mediator-induced activation of xanthine oxidase in endothelial cells; FASEB J 1989, 3:25, 99 – 102

Drs. L. Pruimboom
Disstress als hoofdzakelijke factor bij problemen met het bewegingsapparaat, orthomoleculaire interventies
  1. Inleiding
  2. Common mucosal immune system
  3. Disstress en immuunsuppressie
  4. Ontstekingsmediatoren en behandeling
  5. Schema risicofactoren
  6. Schema onderkennen
  7. Schema behandelen
  8. Literatuur

 

Naar boven